UM partner on FET Flagship proposal on 'Personalised Health Care'
Maastricht University is a partner on a Future Emerging Technologies (FET) Flagship proposal focused on 'Personalised Health Care'. The Personalised Health Care Initiative is a large-scale scientific and technological proposal that will address the grand challenge of developing regenerative, precision and personalised medicine to improve the quality of life of billions of patients worldwide.
Professor in Biofabrication for Regenerative Medicine Lorenzo Moroni (MERLN): “After two years being at the forefront of the organization of such unique opportunity for research and innovation, we are thrilled to have found in Prof. Rui Reis a coordinator of global caliber and have the opportunity to be part of the steering committee of this Flagship proposal. The road is still long in front of us, but we take it step by step with the hope to finish this journey successfully”.
The Personalised Health Care Initiative is a large-scale scientific and technological proposal that will address the grand challenge of developing regenerative, precision and personalised medicine to improve the quality of life of billions of patients worldwide.
The proposal is coordinated by the University of Minho, and is supported by a Steering Committee of 15 members, including Maastricht University, representing academia and industry leaders from across Europe. It is also supposed by a large number of organisations, including over 140 academia and health institutes, 40 research institutes, 95 industry and associations and 25 regional and national authorities.
Through a multi-actor and multi-disciplinary approach, the initiative will focus on the development of targeted and specific therapies for diseases that have an impact on society and the patient, the development of new technologies, and preventive and predictive tools.
FET Flagships are one of the most prestigious, highly-funded, strongest and game-changing instruments of EU research. They will involve a total budget of about €1 billion including EU and public and private funding.